Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
- 1 September 1997
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 389 (6647), 187-190
- https://doi.org/10.1038/38291
Abstract
Much of the predisposition to hereditary breast and ovarian cancer has been attributed to inherited defects in the BRCA1 tumour-suppressor gene1,2,3. The nuclear protein BRCA1 has the properties of a transcription factor4,5,6,7, and can interact with the recombination and repair protein RAD51 (ref. 8). Young women with germline alterations in BRCA1 develop breast cancer at rates 100-fold higher than the general population3, and BRCA1-null mice die before day 8 of development9,10. However, the mechanisms of BRCA1-mediated growth regulation and tumour suppression remain unknown. Here we show that BRCA1 transactivates expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in a p53-independent manner, and that BRCA1 inhibits cell-cycle progression into the S-phase following its transfection into human cancer cells. BRCA1 does not inhibit S-phase progression in p21−/− cells, unlike p21+/+ cells, and tumour-associated, transactivation-deficient mutants of BRCA1 are defective in both transactivation of p21 and cell-cycle inhibition. These data suggest that one mechanism by which BRCA1 contributes to cell-cycle arrest and growth suppression is through the induction of p21.Keywords
This publication has 19 references indexed in Scilit:
- Association of BRCA1 with Rad51 in Mitotic and Meiotic CellsCell, 1997
- Evidence for a transcriptional activation function of BRCA1 C-terminal regionProceedings of the National Academy of Sciences, 1996
- Transcriptional activation by BRCA1Nature, 1996
- The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the MouseCell, 1996
- Location of BRCA1 in Human Breast and Ovarian Cancer CellsScience, 1996
- Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalitiesNature Genetics, 1996
- Aberrant Subcellular Localization of BRCA1 in Breast CancerScience, 1995
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- BRCA1 Mutations in Primary Breast and Ovarian CarcinomasScience, 1994